Literature DB >> 27867607

Liquid biopsy in the practice of neo-oncology.

Smadar Geva1, Laila C Roisman2, Nir Peled1.   

Abstract

Year:  2016        PMID： 27867607      PMCID： PMC5107492          DOI： 10.21037/jtd.2016.10.72

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  15 in total

1.  Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.

Authors:  Siraj M Ali; Thomas Hensing; Alexa B Schrock; Justin Allen; Eric Sanford; Kyle Gowen; Atul Kulkarni; Jie He; James H Suh; Doron Lipson; Julia A Elvin; Roman Yelensky; Zachary Chalmers; Juliann Chmielecki; Nir Peled; Samuel J Klempner; Kashif Firozvi; Garrett M Frampton; Julian R Molina; Smitha Menon; Julie R Brahmer; Heber MacMahon; Jan Nowak; Sai-Hong Ignatius Ou; Marjorie Zauderer; Marc Ladanyi; Maureen Zakowski; Neil Fischbach; Jeffrey S Ross; Phil J Stephens; Vincent A Miller; Heather Wakelee; Shridar Ganesan; Ravi Salgia
Journal:  Oncologist       Date:  2016-05-31

Review 2.  Liquid biopsies: genotyping circulating tumor DNA.

Authors:  Luis A Diaz; Alberto Bardelli
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

Review 3.  Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.

Authors:  Tianhong Li; Hsing-Jien Kung; Philip C Mack; David R Gandara
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

4.  Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing.

Authors:  Alexa B Schrock; Garrett M Frampton; Dana Herndon; Joel R Greenbowe; Kai Wang; Doron Lipson; Roman Yelensky; Zachary R Chalmers; Juliann Chmielecki; Julia A Elvin; Mira Wollner; Addie Dvir; Lior Soussan -Gutman; Rodolfo Bordoni; Nir Peled; Fadi Braiteh; Luis Raez; Rachel Erlich; Sai-Hong Ignatius Ou; Mohamed Mohamed; Jeffrey S Ross; Philip J Stephens; Siraj M Ali; Vincent A Miller
Journal:  Clin Cancer Res       Date:  2016-03-01       Impact factor: 12.531

Review 5.  Development of therapeutic combinations targeting major cancer signaling pathways.

Authors:  Timothy A Yap; Aurelius Omlin; Johann S de Bono
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544

Review 6.  The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.

Authors:  Daniel S W Tan; Sue S Yom; Ming S Tsao; Harvey I Pass; Karen Kelly; Nir Peled; Rex C Yung; Ignacio I Wistuba; Yasushi Yatabe; Michael Unger; Philip C Mack; Murry W Wynes; Tetsuya Mitsudomi; Walter Weder; David Yankelevitz; Roy S Herbst; David R Gandara; David P Carbone; Paul A Bunn; Tony S K Mok; Fred R Hirsch
Journal:  J Thorac Oncol       Date:  2016-05-23       Impact factor: 15.609

Review 7.  Next-generation sequencing to guide cancer therapy.

Authors:  Jeffrey Gagan; Eliezer M Van Allen
Journal:  Genome Med       Date:  2015-07-29       Impact factor: 11.117

Review 8.  Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.

Authors:  Ravi Salgia
Journal:  Expert Rev Mol Diagn       Date:  2016-05-26       Impact factor: 5.225

9.  Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Authors:  Jacob J Chabon; Andrew D Simmons; Alexander F Lovejoy; Mohammad S Esfahani; Aaron M Newman; Henry J Haringsma; David M Kurtz; Henning Stehr; Florian Scherer; Chris A Karlovich; Thomas C Harding; Kathleen A Durkin; Gregory A Otterson; W Thomas Purcell; D Ross Camidge; Jonathan W Goldman; Lecia V Sequist; Zofia Piotrowska; Heather A Wakelee; Joel W Neal; Ash A Alizadeh; Maximilian Diehn
Journal:  Nat Commun       Date:  2016-06-10       Impact factor: 14.919

10.  Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

Authors:  Anna Maria Rachiglio; Riziero Esposito Abate; Alessandra Sacco; Raffaella Pasquale; Francesca Fenizia; Matilde Lambiase; Alessandro Morabito; Agnese Montanino; Gaetano Rocco; Carmen Romano; Anna Nappi; Rosario Vincenzo Iaffaioli; Fabiana Tatangelo; Gerardo Botti; Fortunato Ciardiello; Monica R Maiello; Antonella De Luca; Nicola Normanno
Journal:  Oncotarget       Date:  2016-10-11
View more
  1 in total

Review 1.  The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor.

Authors:  Yating Chen; Wenjie Guo; Junsheng Fan; Yuqing Chen; Xiaoli Zhang; Xin Chen; Peng Luo
Journal:  Cancer Manag Res       Date:  2017-12-07       Impact factor: 3.989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.